Recent Finacing
Recent Raise
C3 Jian is a clinical-stage biotech developing STAMP peptide therapeutics to selectively target oral microbiomes; lead C16G2 targets Streptococcus mutans in Phase 2 rinse, tray, and toothbrush gel formulations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
